EP4069083A1 - Dispositif portable et procédé de détermination d'un photopléthysmogramme - Google Patents

Dispositif portable et procédé de détermination d'un photopléthysmogramme

Info

Publication number
EP4069083A1
EP4069083A1 EP20702099.1A EP20702099A EP4069083A1 EP 4069083 A1 EP4069083 A1 EP 4069083A1 EP 20702099 A EP20702099 A EP 20702099A EP 4069083 A1 EP4069083 A1 EP 4069083A1
Authority
EP
European Patent Office
Prior art keywords
light
proband
wearable device
detector
optical waveguide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP20702099.1A
Other languages
German (de)
English (en)
Other versions
EP4069083B1 (fr
Inventor
Markku Rouvala
Asta Karkkainen
Olli SUHONEN
Nima BAHMANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huawei Technologies Co Ltd
Original Assignee
Huawei Technologies Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huawei Technologies Co Ltd filed Critical Huawei Technologies Co Ltd
Publication of EP4069083A1 publication Critical patent/EP4069083A1/fr
Application granted granted Critical
Publication of EP4069083B1 publication Critical patent/EP4069083B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024—Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6825—Hand
    • A61B5/6826—Finger

Definitions

  • the present disclosure relates generally to the field of wearable devices for health monitoring; and more specifically, to wearable devices and methods for determining a photoplethysmogram.
  • photoplethysmogram is based on illuminating skin of a test subject to non-invasively analyse blood volume changes in underlying microvascular bed of tissue.
  • Photoplethysmogram provides valuable information about cardiovascular and other physiological system, such as changes in blood flow or blood opacity associated with heart beats, breaths, blood oxygen level, and the like.
  • a light emitter is used for illumination purposes in photoplethysmography. The light emitter (e.g.
  • a light-emitting diode is usually the main power consumer in photoplethysmography in a conventional device.
  • a conventional wearable device that is powered by a battery having a limited size, managing power consumption in order to power such light emitter becomes even more challenging.
  • having multiple light emitters may provide better illumination and output signal, but may also have the unwanted effect of quick drainage of the battery or may further result in an increase in size of the conventional wearable device, which is not desirable.
  • Such movements may cause motion artefacts resulting in a much lower accuracy in the health metrics monitored using the conventional wearable device. For example, heart rate monitoring from the wrist or finger is inaccurate because of hand movement.
  • One way to increase accuracy during physical activity or any body movements may be to feed more power to the light emitter to obtain a resultant signal with an acceptable signal quality.
  • increased power consumption has the unwanted effect of draining the battery of the wearable device such that the conventional device may not have enough power to measure a test subject over the course of a day or a week even during non-exercising periods, which is not desirable.
  • the present disclosure seeks to provide a wearable device and a method for determining a photoplethysmogram.
  • the present disclosure seeks to provide a solution to the existing problem of inefficient power management and an error-prone sensing methodology currently used to determine photoplethysmogram that results in inaccurate monitoring of health metrics from a conventional device.
  • An aim of the present disclosure is to provide a solution that overcomes at least partially the problems encountered in prior art, and provides an improved wearable device and method that are able to efficiently manage power consumption and accurately determine photoplethysmogram to obtain accurate heath metrics.
  • the present disclosure provides a wearable device for determining a photoplethysmogram.
  • the wearable device comprises at least a first light source arranged to provide light towards at least one entry point on a proband’s body when the wearable device is used by the proband.
  • the wearable device further comprises at least first light detector arranged to detect light received from the light source through the proband’s body when the wearable device is used by the proband.
  • the wearable device further comprises a control means arranged to calculate a photoplethysmogram based on the detected light.
  • the wearable device further comprises at least a first and a second detector optical waveguide arranged to detect light in at least two different positions on the proband’s body when the wearable device is used by the proband and feed it to the at least first light detector.
  • the wearable device of the first aspect enables to obtain an improved output signal while efficiently managing power consumption.
  • an improved pulsatile physiological waveform i.e. "AC" part of a signal
  • AC pulsatile physiological waveform
  • the first and the second detector optical waveguide are arranged to detect light in at least two different positions on the proband’s body, the chances of interaction with relevant body features, such as arteries, at the proband’ s body is significantly increased.
  • This improved optical setup and sensing methodology increases the number of reading (i.e. measurement) points on the proband’s body covering different body features, thereby increasing accuracy in determination of the photoplethysmogram without any increase in power consumption by the single first light source.
  • the at least first light detector is a photo diode.
  • the signal quality of the output signal is significantly increased resulting in increased accuracy in determination of the photoplethysmogram.
  • the at least first light source is a light-emitting diode.
  • the wearable device further comprises at least a first and a second source optical waveguide arranged to receive light from the at least first light source.
  • the light of the at least first light source is guided by the at least first and the second source optical waveguide to enter the proband’s body through at least two different entry points when in use.
  • the use of the first and a second source optical waveguide to receive light from the at least first light source ensures power efficiency in the wearable device while further increasing accuracy in the determination of the photoplethysmogram.
  • the chances of interaction with relevant body features, such as arteries, at the proband’ s body is significantly increased.
  • enhanced illumination at the at least two different locations also increases the sensing capability of the first light detector, which receives light from the first and the second detector optical waveguide from at least two different positions on the proband’s body.
  • the wearable device comprises one light source, and two light detectors.
  • the power of the "AC" part of the output signal i.e. quality and signal strength of the pulsatile physiological waveform of a photoplethysmography waveform
  • the power of the "AC" part of the output signal is increased without any increase in power consumption by the single light source in the wearable device.
  • the wearable device comprises, for each light source, at least three source optical waveguides for splitting the light from the light source.
  • the increase in the number of the source optical waveguides increases the likelihood of interactions with relevant body features, such as arteries, at the proband’s body without any increase in power consumption by the light source. Further, increased interactions with relevant body features, such as arteries, at the proband’s body increases the accuracy in determination of the photoplethysmogram, which results in accurate monitoring of heath metrics for the proband.
  • the wearable device comprises, for each light detector, at least three detector optical waveguides for detecting light in different positions on the proband’s body.
  • the use of the at least three detector optical waveguides for detecting light in different positions on the proband’s body increases the number of reading (i.e. measurement) points on the proband’s body covering different body features.
  • the increase in the number of reading points increases accuracy in determination of the photoplethysmogram without any increase in power consumption by the light source.
  • the first light source is a tuneable laser.
  • the wearable device further comprises an optical waveguide including a metasurface, the control means being arranged to control the wavelength of the laser to control the position of the at least one entry point.
  • the optical waveguide having the metasurface can be used to direct different light bands to different locations (i.e. different entry points) to enter the proband’s body.
  • the control means by use of the optical waveguide adequately handles such differences in body features (as different locations within a specific range are illuminated), and thus provides accurate measurements consistently for each person.
  • control means is arranged to calculate the photoplethysmogram based on the detected light from all detector optical waveguides of all light detectors.
  • the cumulative signal strength of the output signal (e.g. the power of AC component of the output signal) is increased without any increase in power consumption by the single light source in the wearable device.
  • This improved optical setup and sensing methodology increases the number of reading (i.e. measurement) points on the proband’s body covering different body features, thereby increasing accuracy in determination of the photoplethysmogram without any increase in power consumption by the single first light source.
  • control means is arranged to select at least one detector optical waveguide to calculate the photoplethysmogram based on the detected light from the at least one selected detector optical waveguide.
  • the selection of the at least one detector optical waveguide enables to obtain an output signal having a comparatively higher signal strength (e.g. improved power of AC component of the output signal) measured from at least one point (associated with the at least one detector optical waveguide) as compared to other points on the proband's body.
  • a comparatively higher signal strength e.g. improved power of AC component of the output signal
  • an accuracy in determination of the photoplethysmogram is increased without any increase in power consumption by the first light source.
  • control means is arranged to select at least one of the source optical waveguides to provide light to the proband’s body.
  • the control means may localize an appropriate position of vascular features (e.g. an artery or veins) to provide light to the localized position based on the selection of at least one of the source optical waveguides.
  • vascular features e.g. an artery or veins
  • the interaction with relevant vascular features of the proband's body increases the accuracy in determination of the photoplethysmogram, which enables accurate monitoring of heath metrics for the proband.
  • the wearable device is a watch, a bracelet or a ring.
  • the waveguide enhanced optical setup in the present wearable device improves sensing capability by increasing the number of reading (i.e. measurement) points on the proband’s body covering different body features, thereby reducing any motion artefacts due to hand movements. This further increases the accuracy in determination of the photoplethysmogram without any increase in power consumption by the first light source.
  • the present disclosure provides a use of a wearable device for determining a photoplethysmogram of a proband.
  • the use of the wearable device of the second aspect enables accurate monitoring of heath metrics for the proband, and achieves all the advantages and effects of the wearable device of the first aspect.
  • the present disclosure provides a method of determining a photoplethysmogram of a proband using a device.
  • the method is implemented while the proband is wearing the device.
  • the method comprises emitting light from a first light source towards at least one point on the proband's body.
  • the method further comprises receiving the light by at least a first and a second detector optical waveguide arranged to detect light in at least two different positions on the proband's body, and feeding the received light to a light detector.
  • the method further comprises calculating the photoplethysmogram based on the received light from at least one optical waveguide.
  • the method of the third aspect achieves all the advantages and effects of the wearable device of the first aspect.
  • the method further comprises steps that are performed before the steps of the method of the third aspect, for at least a first and a second different position of the device with respect to the proband.
  • the method further comprises emitting light from the first light source, receiving the light by the at least a first and a second detector optical waveguide, and feeding the received light to the light detector.
  • the method further comprises calculating the photoplethysmogram; determining which one of the first and the second position provides the better result in respect to each other; and positioning the device in the position that was found to provide the better result.
  • the signal quality of the output signal is significantly increased resulting in increased accuracy in determination of the photoplethysmogram.
  • the quality and signal strength of the pulsatile physiological waveform (i.e. AC component) of photoplethysmography waveform is significantly increased without any increase in power consumption by the single light source in the wearable device.
  • FIG. 1 is a block diagram that illustrates various exemplary components of a wearable device, in accordance with an embodiment of the present disclosure
  • FIG. 2 is an illustration of an exemplary scenario for implementation of a wearable device for determining photoplethysmogram, in accordance with an embodiment of the present disclosure
  • FIG. 3 is an illustration that depicts different exemplary positions of vascular features in a body portion of different probands, in accordance with an embodiment of the present disclosure
  • FIG. 4 is an illustration that depicts an output signal derived from a plurality of signals detected at different positions on a body portion of a proband, in accordance with an embodiment of the present disclosure
  • FIG. 5 is an illustration of an exemplary wearable device with a tuneable laser as a light source and an optical waveguide, in accordance with another embodiment of the present disclosure
  • FIG. 6 is a flowchart of a method of determining a photoplethysmogram of a proband using a device, in accordance with an embodiment of the present disclosure.
  • an underlined number is employed to represent an item over which the underlined number is positioned or an item to which the underlined number is adjacent.
  • a non-underlined number relates to an item identified by a line linking the non-underlined number to the item. When a number is non-underlined and accompanied by an associated arrow, the non-underlined number is used to identify a general item at which the arrow is pointing.
  • FIG. 1 is a block diagram that illustrates various exemplary components of a wearable device, in accordance with an embodiment of the present disclosure.
  • a wearable device 102 includes a first light source 104 and one or more light detectors, such as a first light detector 106.
  • the wearable device 102 further includes a control means 108 and a plurality of detector optical waveguides 110, such as first detector optical waveguide 110A and a second detector optical waveguide HOB.
  • a proband 112 associated with the wearable device 102.
  • the wearable device 102 further includes a plurality of source optical waveguides 114, such as a first source optical waveguide 114A and a second source optical waveguide 114B.
  • the wearable device 102 includes suitable logic, circuitry, interfaces and/or code that is configured to determine a photoplethysmogram, for example, for the proband 112 when the wearable device 102 is used by the proband 112.
  • the proband 112 refers to a person (e.g. a user or a given test subject) or any living creature.
  • the photoplethysmogram associated with the proband 112 is potentially used to measure (or indicate) one or more health metrics of the proband's body (hereinafter referred to as a body of the proband 112).
  • the wearable device 102 is potentially used to monitor various health metrics for the body of the proband 112 who may wear the wearable device 102, based on the determined photoplethysmogram.
  • Example of the health metrics that is monitored by wearable device 102 includes, but is not limited to heart rate, heart rate variability (HRV), glucose level, blood pressure, and peripheral capillary oxygen saturation level (SPO2) in the body of the proband 112.
  • HRV heart rate variability
  • SPO2 peripheral capillary oxygen saturation level
  • the wearable device 102 is a watch, a bracelet or a ring.
  • the wearable device 102 is worn by the proband 112 on a wrist or a finger.
  • the wearable device 102 may also be worn (or attached) on an earlobe, neck, or forehead of the body of the proband 112 or any other body portion of the proband 112 that is applicable for the photoplethysmogram.
  • Other examples of the implementation of the wearable device 102 includes, but is not limited to a tech tog, a fashion electronic device, a sports monitoring device, an identification device (e.g. specific heath metrics-based human identification), a medical device, a military device, a gaming device, or other wearable computing device.
  • the first light source 104 is a semiconductor device that emits light (i.e. a light emitter) when supplied with power. Alternatively stated, the first light source 104 is configured to convert electrons when powered in form of photons that are emitted from the first light source 104 in the form of electromagnetic radiation (i.e. as light). The first light source 104 is arranged to provide light towards at least one entry point on the body of the proband 112 when the wearable device 102 is used by the proband 112. In accordance with an embodiment, at least the first light source 104 is a light-emitting diode. In an implementation, the light-emitting diode is an infrared light-emitting diode.
  • the light-emitting diode is a green light-emitting diode.
  • the light-emitting diode is a combination of an infrared light-emitting element and a green light-emitting element, which are alternatively operated in accordance with specified settings. For example, one type of coloured light-emitting element is switched ON' at a time to save power but have the benefit of both the green light and the infrared light wavelength in heath metrics monitoring.
  • at least the first light source 104 is a tuneable laser. The tuneable laser, when in operation, emits a wavelength of red light or near infrared light that is used for illumination of a body portion (e.g.
  • the tuneable laser is configured to emit a wavelength of green light or other wavelengths for illumination purposes.
  • the one or more light detectors such as the first light detector 106, is configured to detect an optical signal (i.e. in form of light) emitted by a light source, such as the first light source 104, after the light propagates through a medium, such as the body of the proband 112.
  • the one or more light detectors act as optical receivers in the wearable device 102.
  • the first light detector 106 is arranged to detect light received from the at least first light source 104 through the body of the proband 112 when the wearable device 102 is used by the proband 112.
  • at least the first light detector 106 is a photo diode.
  • the photo diode is a positive-intrinsic-negative (PIN) diode, an avalanche photo diode, or other type of photo diodes that are able to detect light.
  • the first light detector 106 may be implemented as the avalanche photo diode.
  • the wearable device 102 comprises one light source, such as the first light source 104, and two light detectors, such as the first light detector 106.
  • the control means 108 may include suitable logic, circuitry, interfaces and/or code that is configured to calculate the photoplethysmogram based on the light detected by one or more light detectors, such as the first light detector 106.
  • Examples of the control means 108 may include, but is not limited to a microprocessor, a microcontroller, a complex instruction set computing (CISC) processor, an application-specific integrated circuit (ASIC) processor, a reduced instruction set (RISC) processor, a very long instruction word (VLIW) processor, a central processing unit (CPU), a state machine, a data processing unit, and other processors or circuits.
  • the control means 108 may refer to one or more individual processors, processing devices, or a processing unit that is part of the wearable device 102.
  • the plurality of detector optical waveguides 110 are physical structures that are configured to guide waves, such as electromagnetic waves in the form of light.
  • the plurality of detector optical waveguides 110 captures light at different positions on a body portion (e.g. a finger portion) and directs (or guides) the captured light from the different positions towards a light detector, such as the first light detector 106, with minimal loss of energy.
  • the first detector optical waveguide 110A and the second detector optical waveguide 110B are arranged in the wearable device 102 to detect the light in at least two different positions on the body of the proband 112 when the wearable device 102 is used by the proband 112 and feed the detected light to the first light detector 106.
  • the first detector optical waveguide 110A and the second detector optical waveguide HOB are potentially waveguides having either a constant cross-sectional area or a variable cross- sectional area.
  • the first detector optical waveguide 110A and the second detector optical waveguide 110B may be waveguides having the constant cross-sectional area, such as strip waveguides, rib waveguides, and the like.
  • first detector optical waveguide HOA and the second detector optical waveguide HOB are the waveguides having the variable cross-sectional area, such as segmented waveguides, photonic crystal waveguides, and the like.
  • first detector optical waveguide HOA and the second detector optical waveguide HOB are laser inscribed waveguides, light pipes, optical fibres, and the like.
  • the wearable device 102 further comprises at least the first and the second source optical waveguides 114A and 114B arranged to receive light from the at least first light source 104.
  • Each of the first and the second source optical waveguide 114A and 114B is a physical structure (e.g. an optical fibre) similar to the first detector optical waveguide HOA and the second detector optical waveguide HOB.
  • each of the first and the second source optical waveguide 114A and 114B has a first end and a second end. The first end of each of the first and the second source optical waveguide 114A and H4B is coupled to the first light source 104.
  • each of the first and the second source optical waveguide 114A and 114B is arranged in the wearable device 102 such that the light emitted by the first light source 104 is guided to enter the body of the proband 112 through at least two different entry points when in use.
  • the second end of each of the first and the second source optical waveguide 114A and 114B is potentially in close vicinity or in contact to the two different entry points on the body (e.g. on wrist, finger, neck, forehead, and the like) of the proband 112 when in use.
  • the at least two different entry points are exposed to light guided through the second end of the first and the second source optical waveguide H4A and 114B.
  • each the plurality of source optical waveguides 114 as well as the plurality of detector optical waveguides 110 is constructed using photonic components.
  • a core each the plurality of source optical waveguides 114 as well as the plurality of detector optical waveguides 110 is potentially deposited with a Silicon Nitride (Si x Ny) material for efficient passage of light through it.
  • the first and the second source optical waveguide 114L and 114B are optical waveguides with a metasurface.
  • the first and the second source optical waveguide 114L and 114B are configured to guide the light emitted by the at least first light source 104 to enter the body of the proband 112 through at least two different entry points when in use.
  • An example of the metasurface is shown and described in FIG. 5.
  • the metasurface of the optical waveguides provides a defined surface area that allows the light to enter the body of the proband 112 through various entry points, such as two or more different entry points.
  • Examples of implementation of the first and the second source optical waveguides 114A and 114B are similar to that of the first detector optical waveguide 110A and the second detector optical waveguide 110B as described above.
  • the wearable device 102 comprises, for each light source, at least three source optical waveguides for splitting the light from the light source.
  • the at least three source optical waveguides e.g. the plurality of source optical waveguides 114 splits and guide the light from the light source, such as the first light source 104 towards at least three entry points on the body of the proband 112.
  • the term “splitting” or “split” refers to receiving light from one source point and guiding the same received light to multiple destination points that resemble a separation (or dividing of) of light emitting points.
  • the wearable device 102 comprises, for each light detector, at least three detector optical waveguide detectors for detecting the light in different positions on the body of the proband 112.
  • the at least three detector optical waveguide detectors detects the light in at least three different positions in the body of the proband 112 and feeds it to a light detector (such as the first light detector 106).
  • the proband 112 may wear the wearable device 102 and power ON' the wearable device 102.
  • the wearable device 102 may be communicatively coupled to an external device, such as a smartphone or other display device, via a wired or a wireless communication network.
  • the wearable device 102 may be powered ON' and 'OFF' based on a user input provided by a user of the external device.
  • a hardware button or a user interface may be provided in the wearable device 102 to control the wearable device 12, for example, to switch the wearable device 102, 'ON' or 'OFF'.
  • the wearable device 102 includes the first light source 104 that is arranged to provide the light towards at least one entry point on the body of the proband 112 when the wearable device 102 is used by the proband 112.
  • the first and the second source optical waveguide 114A and 114B are arranged to receive the light from the at least first light source 104.
  • the light of the first light source 104 is guided by the at least first and the second source optical waveguide 114A and 114B to enter the body of the proband through at least two different entry points when in use.
  • at least three source optical waveguides are arranged for splitting the light from the light source in at least three entry points on the body of the proband 112.
  • the control means 108 is arranged to control the wavelength of the first light source 104 to control the position of the at least one entry point (or multiple entry points) on the body of the proband 112.
  • one or more entry points (or locations) on the body of the proband 112 are illuminated with light from each source optical waveguides of the plurality of source optical waveguides 114.
  • different points on skin surface of a finger, a wrist, an earlobe, neck, and the like are illuminated with photons of light that passes through microvascular bed of tissue underlying the exposed skin surface to non-invasively analyse blood volume changes, and potentially other changes in blood, or vascular structures in exposed tissues.
  • the chances of interaction with relevant body features, such as arteries, at the body of the proband 112 is significantly increased.
  • the plurality of detector optical waveguides 110 are arranged to detect the light in at least two different positions on the body of the proband 112 when the wearable device 102 is used by the proband 112 and feed it to a light detector, such as the first light detector 106.
  • the arrangement of at least the first detector optical waveguide 110A and the second detector optical waveguide HOB to detect the light in at least two different positions on the body of the proband 112 is advantageous, as it improves the sensing capability of the wearable device 102 by increasing the number of reading (i.e.
  • the first light detector 106 is arranged to detect the light received from the at least first light source 104 through the body of the proband 112 when the wearable device 102 is used by the proband 112.
  • the first light detector 106 detects the light guided by the first detector optical waveguide 110A and the second detector optical waveguide HOB.
  • the wearable device 102 that includes the control means 108 is arranged to calculate the photoplethysmogram based on the detected light from the body of the proband 112.
  • the accuracy of the calculation of the photoplethysmogram by the wearable device 102 depends on a number of interactions of the light with the body features (specifically the vascular features, such as arteries) in the body of the proband 112. It is observed that greater the number of interactions, higher is the accuracy of the calculated photoplethysmogram.
  • the control means 108 is arranged to calculate the photoplethysmogram based on the detected light from all detector optical waveguides of all light detectors.
  • the plurality of detector optical waveguides 110 such as the first detector optical waveguide 110A and the second detector optical waveguide HOB, feeds light to respective light detectors.
  • having multiple light detectors e.g. the first light detector 106) increases an overall power (or strength) of alternating current (AC) component of signals (e.g. electromagnetic waves or signals in the form of light) detected at all the light detectors.
  • the control means 108 is configured to execute a summation of such signals detected at all the light detectors to obtain a final output signal.
  • An AC component of such summed-up signal (i.e. the final output signal) has increased power resulting in increased accuracy in determination of the photoplethysmogram without any increase in power consumption by the first light source 104.
  • An exemplary summation operation is shown and described, for example, in FIG. 4.
  • control means 108 is arranged to select at least one of the source optical waveguides (e.g. from the plurality of source optical waveguides 114) to provide the light to the body of the proband 112.
  • control means 108 selects one source optical waveguide from the three source optical waveguides for guiding the emitted light from the first light source 104.
  • the control means 108 potentially selects the source optical waveguide that is arranged at a specific position (e.g. an optimal location or an entry point) on the body of the proband 112 that is likely to interact with the vascular feature, such as an artery.
  • the control means 108 is configured to localize an appropriate position of one or more vascular features (e.g. an artery or veins) to provide light to the localized position based on the selection of at least one of the source optical waveguides of the plurality of source optical waveguides 114. Further, such a selection potentially differs for each proband, such as the proband 112.
  • the control means 108 is arranged to select one or more source optical waveguides from the plurality of source optical waveguides 114 for each proband in order to increase interactions of the light with the arteries in the body of corresponding probands.
  • the interaction with relevant vascular features of each proband increases the accuracy in determination of the photoplethysmogram, which enables accurate monitoring of heath metrics consistently for each proband.
  • the control means 108 is arranged to select at least one detector optical waveguide to calculate the photoplethy sm ogram based on the detected light from the at least one selected detector optical waveguide.
  • the control means 108 potentially selects the detector optical waveguide that captures a signal (i.e. an electromagnetic signal or wave in the form of light) having a signal strength that is greater than signal strength of signals captured by other detector optical waveguides.
  • the selection is executed based on the interaction of the light with the arteries in the body of the proband 112.
  • the selection of the at least one detector optical waveguide enables to obtain an output signal having a comparatively higher signal strength (e.g.
  • FIG. 2 is an illustration of an exemplary scenario 200 for implementation of a wearable device for determining photoplethysmogram, in accordance with an embodiment of the present disclosure.
  • FIG. 2 is described in conjunction with elements from FIG. 1.
  • the exemplary scenario 200 that includes a wearable device 202 that is worn on a finger 204.
  • the wearable device 202 is in a form of a ring.
  • the wearable device 202 includes a first light source 206, a first light detector 208, a second light detector 210, a set of source optical waveguides 212, a first set of detector optical waveguides 214, and a second set of detector optical waveguides 216.
  • a dorsal side 218A and a proximal side 218B of the finger 204 that includes an epidermis 218, veins 220, arteries 222, a dorsal phalanx 224, a tendon 226, and a proximal phalanx 228.
  • the wearable device 202 corresponds to the wearable device 102 (FIG. 1).
  • the first light source 206 is a light- emitting diode
  • each of the first light detector 208 and the second light detector 210 is a photo diode.
  • each of the set of source optical waveguides 212, the first set of detector optical waveguides 214, and the second set of detector optical waveguides 216 is an optical fibre.
  • the wearable device 202 potentially includes a battery, a memory for data storage, a network interface, which are not shown for the sake of brevity. The battery powers the first light source 206.
  • the wearable device 202 may be communicatively coupled (e.g. wirelessly) to an external device, such as a smartphone, via the network interface.
  • the first light source 206 is arranged to provide light towards the proximal side 218B of the finger 204, as shown.
  • the set of source optical waveguides 212 e.g. five waveguides in this case
  • the light of the first light source 206 is guided by the set of source optical waveguides 212 to enter the finger 204 through five different entry points through the epidermis 218 (e.g. via the second end of each of the set of source optical waveguides 212 that are exposed towards the epidermis 218, as shown).
  • the epidermis 218 including the underlying tissues, such as the arteries 222 is illuminated at five different points without any additional power consumption by the first light source 206.
  • the reflected light, for example, from the arteries 222, is detected by the first set of detector optical waveguides 214 and the second set of detector optical waveguides 216
  • the first set of detector optical waveguides 214 are arranged at a defined distance from the set of source optical waveguides 212.
  • the first set of detector optical waveguides 214 are arranged to detect light in five different positions on the finger 204, and feed the detected light to the first light detector 208.
  • the second set of detector optical waveguides 216 are arranged at a defined distance from the set of source optical waveguides 212, and approximately opposite to the first set of detector optical waveguides 214 for increased coverage and detection of reflected light from the arteries 222.
  • the second set of detector optical waveguides 216 are arranged to detect light at five different positions on the finger 204, and to feed the detected light to the second light detector 210.
  • the first light detector 208 receives light (e.g. a first signal in the form of electromagnetic radiation, i.e. light) from the first set of detector optical waveguides 214 and the second light detector 210 receives light (e.g. a second signal in the form of electromagnetic radiation, i.e. light) from the second set of detector optical waveguides 216.
  • the control means 108 is configured to calculate a photoplethysmogram based on the detected light at the first light detector 208 and the second light detector 210. The detected light over a period of time indicates how the reflected and scattered light intensity changes with each pulse of blood flow.
  • the scattered light intensity usually changes in time with respect to changes in blood flow or blood opacity associated with heart beats, breaths, blood oxygen level (SPO2), and the like.
  • the waveguide enhanced optical setup in the wearable device 202 improves sensing capability of the wearable device 202 by increasing the number of reading (i.e. measurement) points on the body of the proband 112 covering different vascular features, such as the arteries 222, thereby reducing any motion artefacts due to hand movements, and increasing accuracy in determination of the photoplethysmogram without any increase in power consumption by the first light source 206.
  • the increase in the number of reading (i.e. measurement) points on the body of the proband 112 covering different vascular features, such as the arteries 222 enables to measure even small or otherwise conventionally undetected changes in the quantity of scattered photons that indicates varying blood flow.
  • the control means 108 is configured to execute a summation of the signals (i.e. the first signal and the second signal) detected at the first light detector 208 and the second light detector 210 to obtain a final output signal.
  • the reflected light detected by the first light detector 208 and the second light detector 210 is converted into the electrical signal comprising an alternating current (AC) part and a direct current (DC) part by corresponding light detectors, such as the first light detector 208 and the second light detector 210.
  • the photoplethysmogram waveform i.e. the final output signal
  • the photoplethysmogram waveform includes a pulsatile ('AC') physiological waveform that is usually superimposed on a slowly varying ('DC') baseline.
  • the quality and strength of the pulsatile physiological waveform (i.e. 'AC component or part) of the final output signal that is attributed to, for example, cardiac synchronous changes in the blood volume with each heartbeat, is significantly increased without any increase in power consumption by the first light source 206 in the wearable device 202.
  • the pulsatile ('AC') physiological waveform of the output signal is potentially used for accurate measurement of accurate heart bit rates even if a proband, such as the proband 112 is performing a physical activity or hand movements.
  • the slowly varying baseline waveform (i.e. the DC part) of the output signal may be used to measure certain other heath metrics such as respiration, sympathetic nervous system activity, and thermoregul ation .
  • FIG. 3 is an illustration that depicts different exemplary positions of vascular features in a body portion of different probands, in accordance with an embodiment of the present disclosure.
  • FIG. 3 is described in conjunction with elements from FIGs. 1 and 2.
  • FIG. 3 there is shown exemplary positions of arteries 302A, 302B, 302C, 302D, and 302E which are different in respective finger portions 304A, 304B, 304C, 304D, and 304E of different probands.
  • the appropriate positions of corresponding light source 306A, 306B, 306C, 306D, and 306E are different for different probands.
  • the appropriate positions of light detectors 308A, 308B, 308C, 308D, and 308E for respective finger portions 304A, 304B, 304C, 304D, and 304E of different probands are different.
  • the positions of vascular features, such as the arteries 302A, 302B, 302C, 302D, and 302E in the same body portion (i.e. a finger) vary for different probands.
  • the optimized positions to illuminate as well as detect light also vary for different probands.
  • the position of a light-emitting diode 310 i.e.
  • a light source for emitting light and also the positions of photodiodes 312 for capturing signals in the form of light are potentially arranged or localized in a specified range in a ring 314 (i.e. a wearable device).
  • a ring 314 i.e. a wearable device.
  • FIG. 4 is an illustration that depicts an output signal derived from a plurality of signals detected at different positions on a body portion of a proband, in accordance with an embodiment of the present disclosure.
  • FIG. 4 is described in conjunction with elements from FIGs. 1, 2, and 3.
  • a portion of a wearable device 402 having a first light source 404 and four light detectors, such as a first light detector 406, a second light detector 408, a third light detector 410, and a fourth light detector 412.
  • an AC component of each of a first signal 414A, a second signal 414B, a third signal 414C, a fourth signal 414D There is further shown an AC component of each of a first signal 414A, a second signal 414B, a third signal 414C, a fourth signal 414D.
  • the first signal 414A, the second signal 414B, the third signal 414C, and the fourth signal 414D are detected at the first light detector 406, the second light detector 408, the third light
  • a microprocessor 416 (e.g. an example of the control means 108 of FIG. 1) is configured to execute a summation of the first signal 414A, the second signal 414B, the third signal 414C, and the fourth signal 414D to obtain an output signal 418 having an AC component with increased power resulting in increased accuracy in determination of the photoplethysmogram by the microprocessor 416 without any increase in power consumption by the first light source 404.
  • FIG. 5 is an illustration of an exemplary wearable device 502 with a tuneable laser
  • FIG. 5 is described in conjunction with elements from FIGs. 1, 2, 3, and 4.
  • the wearable device 502 that includes the tuneable laser 504 as the light source.
  • the optical waveguide 506 with the metasurface 508 arranged at an inner side of the wearable device 502.
  • the wearable device 502 is in the form of a ring which can be worn on a finger portion 510.
  • the tuneable laser 504 may be a tuneable hybrid silicon/III-V laser, known in the art.
  • the tuneable hybrid silicon/III-V laser may include a silicon photonic integrated circuit transmitter composed of hybrid Ill-V/silicon lasers and silicon Mach-Zehnder modulators (MZM) operating in a specified wavelength window.
  • MZM Mach-Zehnder modulators
  • control means 512 of the wearable device 502 is configured to control a wavelength of the tuneable laser 504 to direct different light bands to different locations (i.e. different entry points towards the finger portion 510) via the optical waveguide 506 having the metasurface 508 provided in the inner side of the wearable device 502.
  • FIG. 6 is a flowchart of a method 600 of determining a photoplethysmogram of a proband using a device, in accordance with an embodiment of the present disclosure.
  • FIG. 6 is described in conjunction with elements from FIGs. 1 to 5.
  • the method 600 is executed by a wearable device 102, 202, 402, or 502 described, for example, in Figs. 1 to 5.
  • the method 600 includes steps 602 and 608.
  • step 602 light is emitted from a first light source towards at least one point on the proband's body (such as the proband 112).
  • the first light source are the first light source 104, 206, or 404, the light sources 306A, 306B, 306C, 306D, or 306E, or the tuneable laser 504, shown and described, for example, in FIGs. 1 to 5.
  • the light is received by at least a first and a second detector optical waveguide arranged to detect light in at least two different positions on the proband's body.
  • the first and the second detector optical waveguide are the plurality of detector optical waveguides 110 (such as the first detector optical waveguide 110A and the second detector optical waveguide HOB), the first set of detector optical waveguides 214, the second set of detector optical waveguides 216, or the optical waveguide 506, shown and described, for example, in FIGs. 1, 2, and 5.
  • the received light is fed to a light detector.
  • Examples of the light detector are the first light detector 106, 208, or 406, a second light detector 210 or 408, the light detectors 308A, 308B, 308C, 308D, and 308E, the third light detector 410, or the fourth light detector 412, shown and described, for example, in FIGs. 1 to 5.
  • a photoplethysmogram is calculated based on the received light from at least one optical waveguide.
  • the photoplethysmogram is calculated based on the light received at the plurality of detector optical waveguides 110.
  • the control means 108 (FIG. 1) is arranged to calculate the photoplethysmogram based on the detected light from the body of the proband 112.
  • the method 600 further comprises performing certain operations or steps before the steps 602 to 608 for at least a first and a second different position of the device (such wearable device 102, 202, 402, or 502) with respect to the proband 112.
  • Such operations or steps include emitting light from the first light source 104, 206, or 404; receiving the light by the at least the first detector optical waveguide 110A and the second detector optical waveguide 110B, and feeding the received light to the light detector (such as first light detector 106, 208, or 406).
  • the method 600 further includes calculating the photoplethysmogram and determining which one of the first and the second position provides a better result with respect to each other.
  • control means 108 is configured to perform a test run (or a simulation or an experimentation) to localize an appropriate position of vascular features (e.g. an artery or veins) to provide light to the localized position for the first and the second different position of the device (such wearable device 102, 202, 402, or 502) with respect to the proband 112.
  • the better result refers to an accuracy level of the measurements of health metrics based on the calculated photoplethysmogram for the first and the second different position of the device (such wearable device 102, 202, 402, or 502).
  • the method 600 further includes positioning the device in the position that was found to provide the better result.
  • the device is positioned accordingly.
  • the signal quality of the output signal is significantly increased resulting in increased accuracy in determination of the photoplethysmogram.
  • the quality and signal strength of the pulsatile physiological waveform (i.e. AC component) of the output signal is significantly increased without any increase in power consumption by the first light source 104, 206, or 404

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

La présente invention concerne un dispositif portable pour déterminer un photopléthysmogramme qui comprend au moins une première source de lumière agencée pour fournir de la lumière vers au moins un point d'entrée sur le corps d'un proband lorsque le dispositif portable est utilisé par le proband. Le dispositif portable comprend en outre au moins un premier détecteur de lumière agencé pour détecter la lumière reçue depuis la source de lumière à travers le corps du proband. Le dispositif portable comprend en outre un moyen de commande agencé pour calculer un photopléthysmogramme sur la base de la lumière détectée. Le dispositif portable comprend en outre au moins des premier et deuxième guides d'ondes optiques de détecteur agencés pour détecter la lumière dans au moins deux positions différentes sur le corps du proband lorsque le dispositif portable est utilisé par le proband et transférer celle-ci à l'au moins un premier détecteur de lumière.
EP20702099.1A 2020-01-24 2020-01-24 Dispositif portable et procédé de détermination d'un photopléthysmogramme Active EP4069083B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2020/051723 WO2021148131A1 (fr) 2020-01-24 2020-01-24 Dispositif portable et procédé de détermination d'un photopléthysmogramme

Publications (2)

Publication Number Publication Date
EP4069083A1 true EP4069083A1 (fr) 2022-10-12
EP4069083B1 EP4069083B1 (fr) 2023-10-25

Family

ID=69232843

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20702099.1A Active EP4069083B1 (fr) 2020-01-24 2020-01-24 Dispositif portable et procédé de détermination d'un photopléthysmogramme

Country Status (3)

Country Link
EP (1) EP4069083B1 (fr)
CN (1) CN115023185A (fr)
WO (1) WO2021148131A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116968084B (zh) * 2023-09-22 2023-12-15 常熟理工学院 一种外骨骼绑缚装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7225005B2 (en) * 2004-12-14 2007-05-29 Intelligent Medical Devices, Inc. Optical determination of in vivo properties
US8781548B2 (en) * 2009-03-31 2014-07-15 Covidien Lp Medical sensor with flexible components and technique for using the same
US10536768B2 (en) * 2014-08-06 2020-01-14 Valencell, Inc. Optical physiological sensor modules with reduced signal noise
KR102434701B1 (ko) * 2015-09-01 2022-08-22 삼성전자주식회사 생체 정보 획득 장치 및 생체 정보 획득 방법과 생체 정보 검사 장치
US10702211B2 (en) * 2016-07-15 2020-07-07 Apple Inc. Sensor window with integrated isolation feature

Also Published As

Publication number Publication date
CN115023185A (zh) 2022-09-06
WO2021148131A1 (fr) 2021-07-29
EP4069083B1 (fr) 2023-10-25

Similar Documents

Publication Publication Date Title
US20210393150A1 (en) Bio-information measuring apparatus and bio-information measuring method
US10646145B2 (en) Reflective SpO2 measurement system and method
US11317814B2 (en) Systems and methods for collecting physiological information of a user
KR101225849B1 (ko) 2개의 파장을 갖는 광파를 이용하는 맥박 측정 방법 및 장치
CN105078438B (zh) 脉搏周期检测设备和方法和可穿戴电子设备
US20190008396A1 (en) Concave optical sensors
KR20160090125A (ko) 생체 정보 검출 장치
KR102480197B1 (ko) 생체정보 추정 장치 및 방법
KR20150068279A (ko) 자기 정렬 센서 어레이 및 그것의 자기 정렬하기 위한 방법
US20200383628A1 (en) Optical response measurement from skin and tissue using spectroscopy
CN113197553A (zh) 电子设备及生物信息检测方法
KR102605901B1 (ko) 생체정보 추정 장치 및 방법
KR102567952B1 (ko) 생체정보 추정 장치 및 방법
EP4069083B1 (fr) Dispositif portable et procédé de détermination d'un photopléthysmogramme
CN110381830A (zh) 测量装置、测量方法以及程序
CN110035695B (zh) 用于生理测量传感器的传感器装置
KR102630393B1 (ko) 생체정보 측정 장치 및 방법
US9730644B1 (en) Circuits and methods for selecting a mode of operation of a photoplethysmographic sensor
KR20190105421A (ko) 광혈류 측정기 기반의 인체착용형 혈압 측정장치 및 혈압 측정방법
KR102576126B1 (ko) 생체정보 추정 장치 및 방법
JP2004016279A (ja) 体動検出装置および体動検出方法
CN107661094B (zh) 用于光体积描记传感器的电路及方法
US20220104714A1 (en) Apparatus and method for estimating bio-information
US20220039666A1 (en) Apparatus and method for estimating bio-information
KR20170064906A (ko) 생체신호 측정장치 및 방법

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220707

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20230605

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602020019781

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231130

Year of fee payment: 5

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20231025

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1623819

Country of ref document: AT

Kind code of ref document: T

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240225

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240225

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240126

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240125

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240226

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20231205

Year of fee payment: 5